JPMorgan Shares Hold Near $361 Despite $100 Million Fraud-Claim Scrutiny
Updated
Updated · ts2.tech · Aug 6
JPMorgan Shares Hold Near $361 Despite $100 Million Fraud-Claim Scrutiny
2 articles · Updated · ts2.tech · Aug 6
Summary
$361.49 premarket trading left JPMorgan up 0.63% after a Wall Street Journal report on allegations tied to more than $100 million in denied reimbursements, though only 2,254 shares changed hands.
The scrutiny stems from former scam-prevention chief Christy Lillie’s complaint that some losses were labeled scams rather than fraud, a distinction that can affect Regulation E reimbursement obligations.
Prosecutors earlier this year reviewed the allegations and Treasury officials reportedly received documents, but no wrongdoing has been alleged; JPMorgan said the claims lack merit and its internal review found no legal breaches.
The reported $100 million minimum would equal about 0.59% of second-quarter profit excluding notable items but 86% of quarterly legal expense, sharpening investor focus on control and compliance costs.
That risk lands as JPMorgan trades near record highs with a 17.2 P/E and an average analyst target of $359.33, leaving little valuation cushion if the review expands.